Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019630785> ?p ?o ?g. }
- W2019630785 endingPage "516" @default.
- W2019630785 startingPage "495" @default.
- W2019630785 abstract "Multiple genetic and nongenetic factors can modify the action of a drug, resulting in varied responses to a particular drug across different individuals. Personalized medicine incorporates the comprehensive knowledge of these factors to facilitate the selection of optimal therapy, reduce adverse drug reactions, increase patient compliance and increase the efficiency of therapy. Pharmacogenomics, which integrates the knowledge of an individual’s genetic make-up for diagnostic decisions or therapeutic interventions is closely linked to personalized medicine, and is being increasingly used to prevent adverse drug reactions. There are various reports on genetic associations between particular HLA allotypes and drug hypersensitivities and the strongest associations reported thus far, are with the reverse transcriptase inhibitor, abacavir and HLA-B*5701, the gout prophylactic allopurinol and HLA-B*5801 and the antiepileptic carbamazepine and B*1502, providing a defined disease trigger and suggesting a general mechanism for these associations. Recognizing the strong HLA association, the US FDA has recommended genetic testing before starting abacavir and carbamazepine therapies. To incorporate HLA testing for other drug hypersensitivities and life-threatening reactions it is essential first to establish clear HLA associations, and second, to understand the immune-mechanism by which these drugs induce HLA-linked hypersensitivity. The latter will provide insight into the pathologic mechanisms of drug allergy allowing rational immunotherapy for these life-threatening reactions and the development of alternative drug therapies for hypersensitive patients." @default.
- W2019630785 created "2016-06-24" @default.
- W2019630785 creator A5002908830 @default.
- W2019630785 creator A5009573818 @default.
- W2019630785 creator A5024693699 @default.
- W2019630785 date "2010-09-01" @default.
- W2019630785 modified "2023-10-17" @default.
- W2019630785 title "Personalized medicine for HLA-associated drug-hypersensitivity reactions" @default.
- W2019630785 cites W1489147212 @default.
- W2019630785 cites W1558433062 @default.
- W2019630785 cites W1588835655 @default.
- W2019630785 cites W1927148985 @default.
- W2019630785 cites W1948059877 @default.
- W2019630785 cites W1955016433 @default.
- W2019630785 cites W1967361736 @default.
- W2019630785 cites W1968073144 @default.
- W2019630785 cites W1968439455 @default.
- W2019630785 cites W1970924226 @default.
- W2019630785 cites W1972437174 @default.
- W2019630785 cites W1974909480 @default.
- W2019630785 cites W1977887519 @default.
- W2019630785 cites W1978069717 @default.
- W2019630785 cites W1978862846 @default.
- W2019630785 cites W1983017735 @default.
- W2019630785 cites W1984844168 @default.
- W2019630785 cites W1985710645 @default.
- W2019630785 cites W1986541127 @default.
- W2019630785 cites W1991088839 @default.
- W2019630785 cites W1994103000 @default.
- W2019630785 cites W1994872511 @default.
- W2019630785 cites W1995968109 @default.
- W2019630785 cites W1997549444 @default.
- W2019630785 cites W1998146750 @default.
- W2019630785 cites W1998970549 @default.
- W2019630785 cites W2001686065 @default.
- W2019630785 cites W2003268732 @default.
- W2019630785 cites W2003678292 @default.
- W2019630785 cites W2006240275 @default.
- W2019630785 cites W2008784877 @default.
- W2019630785 cites W2011541285 @default.
- W2019630785 cites W2011787625 @default.
- W2019630785 cites W2014569071 @default.
- W2019630785 cites W2019464839 @default.
- W2019630785 cites W2021318193 @default.
- W2019630785 cites W2022085508 @default.
- W2019630785 cites W2023226761 @default.
- W2019630785 cites W2025161685 @default.
- W2019630785 cites W2026186807 @default.
- W2019630785 cites W2028824925 @default.
- W2019630785 cites W2032039529 @default.
- W2019630785 cites W2032708132 @default.
- W2019630785 cites W2033180759 @default.
- W2019630785 cites W2034570525 @default.
- W2019630785 cites W2035153413 @default.
- W2019630785 cites W2035790484 @default.
- W2019630785 cites W2036592937 @default.
- W2019630785 cites W2037536577 @default.
- W2019630785 cites W2043762183 @default.
- W2019630785 cites W2044833878 @default.
- W2019630785 cites W2045377848 @default.
- W2019630785 cites W2047309488 @default.
- W2019630785 cites W2047429000 @default.
- W2019630785 cites W2049377340 @default.
- W2019630785 cites W2049397123 @default.
- W2019630785 cites W2049902892 @default.
- W2019630785 cites W2051736603 @default.
- W2019630785 cites W2051808004 @default.
- W2019630785 cites W2052984278 @default.
- W2019630785 cites W2053449731 @default.
- W2019630785 cites W2053896303 @default.
- W2019630785 cites W2055076454 @default.
- W2019630785 cites W2055128986 @default.
- W2019630785 cites W2055354849 @default.
- W2019630785 cites W2059179441 @default.
- W2019630785 cites W2060575095 @default.
- W2019630785 cites W2060588878 @default.
- W2019630785 cites W2060826014 @default.
- W2019630785 cites W2061057762 @default.
- W2019630785 cites W2061631865 @default.
- W2019630785 cites W2064384292 @default.
- W2019630785 cites W2066592806 @default.
- W2019630785 cites W2066675435 @default.
- W2019630785 cites W2068231570 @default.
- W2019630785 cites W2072549117 @default.
- W2019630785 cites W2073057919 @default.
- W2019630785 cites W2073739597 @default.
- W2019630785 cites W2073884742 @default.
- W2019630785 cites W2074807009 @default.
- W2019630785 cites W2075817888 @default.
- W2019630785 cites W2078956283 @default.
- W2019630785 cites W2081661453 @default.
- W2019630785 cites W2083508836 @default.
- W2019630785 cites W2086796885 @default.
- W2019630785 cites W2087094124 @default.
- W2019630785 cites W2088162928 @default.
- W2019630785 cites W2089378839 @default.
- W2019630785 cites W2094745053 @default.
- W2019630785 cites W2102942667 @default.